Compare AMPH & ELVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMPH | ELVR |
|---|---|---|
| Founded | 1996 | 2000 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2005 | 2018 |
| Metric | AMPH | ELVR |
|---|---|---|
| Price | $28.85 | $25.39 |
| Analyst Decision | Hold | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.50 | N/A |
| AVG Volume (30 Days) | ★ 415.9K | 63.7K |
| Earning Date | 11-05-2026 | 10-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $719,887,000.00 | N/A |
| Revenue This Year | $3.81 | $40.12 |
| Revenue Next Year | $4.91 | $16.85 |
| P/E Ratio | $17.10 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.65 | $21.32 |
| 52 Week High | $31.00 | $102.80 |
| Indicator | AMPH | ELVR |
|---|---|---|
| Relative Strength Index (RSI) | 64.24 | 41.84 |
| Support Level | $27.24 | $21.32 |
| Resistance Level | $29.35 | $27.67 |
| Average True Range (ATR) | 1.07 | 1.18 |
| MACD | 0.15 | 1.09 |
| Stochastic Oscillator | 61.97 | 57.81 |
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.
Elevra Lithium Ltd is a mineral exploration and development company. The principal activity of the company is lithium mining and processing at North American Lithium(NAL) and ongoing identification, evaluation and development of its world-wide portfolio of mineral exploration assets, predominantly focusing on lithium. Its segments are North American Lithium, and All other operations. Majority of revenue comes from North American Lithium. It has presence in China, and USA. Majority of revenue comes from China.